Rigel Pharmaceuticals (NASDAQ:RIGL) Earns “Buy” Rating from HC Wainwright - Defense World

Rigel Pharmaceuticals (NASDAQ:RIGL) Earns “Buy” Rating from HC Wainwright  Defense World